Antabuse in Severe Alcoholism: an Open Controlled Study

Psykiatrisk Center Gentofte60 enrolled

Overview

Newly detoxified alcoholics (N=60) are randomised to either antabuse (disulfiram) treatment or the control group for a total of 6 months.All patients will receive cognitive behavioural treatment in groups. The hypothesis to be tested is that more of the patients who receive antabuse (disulfiram) will be alcohol free during the 6 months treatment period compared to the control group. The trial is open.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Alcoholism

Interventions

antabuse (disulfiram)DRUG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Alcoholism * Living in the departments catchment area Exclusion Criteria: * Pregnancy * Schizophrenia * Bipolar disorder * Other substance abuse * Dementia * Anorexia

Locations (1)

Psykiatrisk Center Gentofte

Hellerup, Denmark

RECRUITING

Outcomes

Primary Outcomes

The number of patients in each group who have not been drinking alcohol after 6 months of treatment.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.